Looking to publish in JAC-Antimicrobial Resistance? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJAC-Antimicrobial Resistance is an Oxford Academic journal of the British Society for Antimicrobial Chemotherapy focused on antimicrobial resistance and related peer-reviewed research and resources. It is a fully open access journal and highlights average manuscript processing times and APC support options including institutional agreements, LMIC waivers, and a BSAC member discount.
Looking to publish in JAC-Antimicrobial Resistance? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
JAC-Antimicrobial Resistance accepts the following article types. Click on an article type to view submission instructions.
Original Research Articles
Review Articles
Systematic Review Articles
Brief Reports
Correspondence
Recent Publications
Carbapenem-resistant Acinetobacter baumannii in resource-limited ICUs: when ‘recommended therapy’ is not realistically deliverable
Mohammad Saquib Alam, Nagma Khatoon
Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
-
Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes
Mary Rimbi, Simon Pybus, Sophie Dodds, Beth White, Neil Ritchie, R Andrew Seaton
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
Jun Morita, Kazuya Ishiwata, Shogo Matsumoto, Seiji Kato, Gemma Attley, Katie Patel, Ignacio Rodriguez, Navita Mallalieu
In vitro activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan
Katsunori Yanagihara, Kazuhiro Tateda, Yohei Doi, Satoshi Takahashi, Hiroki Ohge, Koju Itahashi, Hayato Okade, Hiroshige Mikamo
Frequently asked questions
How long does it take to publish?
33 days to first decision; 12 days in review; 19 days from acceptance to advance access publication
Reformat to JAC-Antimicrobial Resistance using Livewrite PremiumIs a cover letter required?
A covering letter is required to declare previous publication of the material, any previous submission of the work to the journal, important in-press or submitted papers, prior publication of clinical trial data in results databases, and use of LLM tools.
Reformat to JAC-Antimicrobial Resistance using Livewrite PremiumWhat are the publication costs?
Standard article processing charge with APC waivers for eligible LMIC authors and a 20% discount for BSAC members
Reformat to JAC-Antimicrobial Resistance using Livewrite Premium